Ascension Ventures joins $106M investment round for healthcare AI startup Olive 

Healthcare workforce artificial intelligence startup Olive closed $106 million in a financing round that included participation from St. Louis-based Ascension’s healthcare venture fund, according to a Sept. 17 news release. 

Advertisement

The latest financing round brings Olive’s total fundraising total to more than $220 million to date. 

The company’s AI workforce technology, which has been adopted by more than 600 hospitals, helps automate tasks in various departments such as IT, supply chain, revenue cycle and clinical administration. 

This year, Olive has reported a surge in demand for its AlphaSites, on-site command centers that deploy and manage AI workers to measure value for health systems. The company’s team has grown to more than 360 employees this year, with 67 new workers joining in August. 

More articles on artificial intelligence: 
‘AI will dazzle but also disappoint’: 6 health system exec predictions on artificial intelligence
5 recent studies exploring AI in healthcare
Google.org backs VUMC, UNC study on how COVID-19 alters gene expression

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Innovation

Advertisement

Comments are closed.